Comparative assessment of off-label and unlicensed drug prescription in neonatal intensive care: FDA versus Brazilian guidelines Haline Tereza Matias Lima Costa; Arlan Peres Florencio; Priscilla Karilline do Vale Bezerra; Jéssica Escorel Chaves Cavalcanti; Tatiana Xavier Costa; Flavia Evelyn Medeiros Fernandes; Martins Rand Randall;

Off-label pediatric medicines in Spain Roi Piñeiro Pérez; Esmeralda Núñez Cuadros; Belén Rodríguez Marrodán; Raquel Escrig Fernández; María Ángeles Gil Lemus; Santiago Manzano Blanco; Cristina Calvo;

Epidemiology and risk factors for bronchopulmonary dysplasia in preterm infants born at or less than 32 weeks of gestation Andrea Sucasas Alonso; Sonia Pértega Diaz; Rebeca Sáez Soto; Alejandro Avila-Alvarez;